The won may weaken further as South Korean President Yoon Suk Yeol’s actions have likely undermined investor confidence in Korea, TD Securities’ said.
Mesoblast (ASX:MSB) has announced that the US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced ...